Clinical evaluation of the hepatitis safety of a β-propiolactone/ultraviolet treated factor IX concentrate (PPSB)
- 1 October 1982
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 28 (1) , 75-83
- https://doi.org/10.1016/0049-3848(82)90035-4
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Effect of Combined Treatment of Serum Containing Hepatitis B Virus with Beta‐Propiolactone and Ultraviolet IrradiationVox Sanguinis, 1981
- Incomplete Inactivation of Hepatitis B Virus after Heat Treatment at 60 C for 10 HoursThe Journal of Infectious Diseases, 1978
- Incidence of Viral Hepatitis after Administration of Factor IX ConcentratesVox Sanguinis, 1976
- Hepatitis B Associated with KonyneNew England Journal of Medicine, 1972
- Hepatitis and clotting-factor concentratesPublished by American Medical Association (AMA) ,1972
- Hepatitis after konyne administrationne administrationDigestive Diseases and Sciences, 1972
- Hepatitis after Konyne AdministrationNew England Journal of Medicine, 1971
- Factor IX Concentrate and Viral HepatitisAnnals of Internal Medicine, 1971